Maham Fatima
Thu, May 14, 2026 astatine 6:33 AM CDT 2 min read
Performance varied importantly by region, with the US conception seeing an 8% gross diminution to $1.1 cardinal owed to little companion carnal merchandise income and generic competition. In contrast, the International conception grew 17% to $1.1 billion, driven by beardown request successful livestock and parasiticides, arsenic good arsenic a $100 cardinal payment from fiscal twelvemonth reporting alignments. Livestock income remained a agleam spot globally, with a 7% integrated summation successful the US and a 14% summation internationally.
Zoetis Inc. (NYSE:ZTS) revised its full-year 2026 gross guidance to betwixt $9.68 and $9.96 billion, representing integrated maturation of 2% to 5%. The institution remains focused connected its pipeline of implicit 12 imaginable blockbusters and its pending acquisition of Neogen’s carnal genomics business, expected to adjacent successful H2 2026.
Zoetis Inc. (NYSE:ZTS) is simply a planetary carnal wellness institution that discovers, develops, manufactures, and commercializes vaccines, medicines, biodevices, familial tests, diagnostic products, and precision carnal health.
While we admit the imaginable of ZTS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey connected Google News.

6 hours ago
1





English (CA) ·
English (US) ·
Spanish (MX) ·